Business
Connecticut adult-use marijuana sales set to start with big opportunities, few operators
A handful of medical marijuana dispensaries in Connecticut on Tuesday will expand into adult-use retail, establishing another new market on the Eastern Seaboard with sales expected to hit at least $300 million this year.
The state’s adult-use market, dominated by multistate operators, will open with only 13 cannabis companies of any kind licensed to take part in Day One sales, one of the smaller cohorts among U.S. recreational launches.
Dispensaries expect an initial surge in demand, reflecting customer enthusiasm, novelty factors and limited retail access.
Some stores are a 30-minute drive or longer from their nearest competitor.
“A deluge is coming, and we expect hundreds of thousands more potential customers plus whomever might come from neighboring states,” said Benjamin Zachs, CEO of Fine Fettle Dispensary, which has converted three of its four medical marijuana licenses into hybrid retail permits to serve recreational consumers.
Connecticut is the third East Coast state to usher in adult-use sales in just over a month, following New York’s Dec. 29 opening and Rhode Island’s Dec. 1 debut.
Recreational sales this year in Connecticut are projected to reach $300 million to $375 million, growing to $650 million-$800 million in 2026, according to the 2022 MJBiz Factbook.
Prepping for a new day
To ensure smooth transactions and an enjoyable shopping experience, Acreage Holdings implemented several initiatives at The Botanist in Montville, the multistate operator’s first dispensary to launch adult-use sales in Connecticut.
“We’ve added more point-of-sale terminals, reconfigured the lobby layout and dispensary flow, hired more employees, doubled our parking availability and so much more,” said Dennis Curran, chief operating officer of New York-based Acreage.
Acreage plans to convert its sister locations in Danbury and South Windsor to recreational stores later this year.
Fine Fettle has been prepping its dispensaries for weeks for a rush of new customers on opening day.
Efforts included hiring about 100 employees and adding several registers in each location, according to Zachs.
Its dispensaries serve about 9,000 medical marijuana patients in Connecticut, roughly 20% of the total market.
In one of several regulatory policies aimed at mitigating product shortfalls at rollout, sales to adult-use consumers will be limited to a quarter of an ounce of cannabis flower or product equivalent.
Massachusetts-based MSO Curaleaf Holdings, which operates four MMJ dispensaries and has a cultivation license in Connecticut, has applied to convert two of its stores to hybrid retail.
“We hope to begin adult-use sales in Stamford in the coming days,” CEO Matt Darin told MJBizDaily.
Though Curaleaf dispensaries will initially be omitted from the adult-use market, all seven of the state’s licensed recreational retail stores will carry its products, according to Darin.
“These products include Curaleaf flower and pre-rolls as well as Select Cliq, our proprietary vape hardware system, and Select Squeeze, our fast-acting THC-infused beverage enhancer,” he said.
High cost of admission
Connecticut retailers and marijuana producers might face the highest premiums in the country to convert their medical marijuana licenses to hybrid retail operations.
Dispensaries are charged a $1 million fee and producers a $3 million fee, though those rates could be cut in half if businesses agree to form separate joint ventures with two social equity applicants, an allowance that includes two additional licenses.
Most, if not all, cannabis business license applicants in Connecticut are expected to take this option, industry sources and operators told MJBizDaily.
The initial rollout includes only four producers – a catchall term for vertically integrated cultivators and manufacturers in Connecticut – which is the same number of licensees that were selected in 2014 to supply the state’s medical marijuana program.
Three of them – CT Pharmaceutical Solutions (now known as CT Pharma), Curaleaf and Theraplant – still operate under the same or similar names.
Theraplant and CT Pharma were acquired in 2021 by The Greenrose Holding Co., a special purpose acquisition company (SPAC), and Chicago-based Verano Holdings, respectively.
Connecticut’s high compliance costs could further jeopardize Greenrose’s financial position, which has teetered for well over a year.
The SPAC, in recent SEC filings, disclosed it missed a quarterly financial reporting deadline, broke credit agreements and needs “substantial additional capital” to fund ongoing operations.
Greenrose did not respond to inquiries from MJBizDaily.
“It’s something we’re aware of and monitoring,” said Kaitlyn Krasselt, spokesperson for the Connecticut Department of Consumer Protection (DCP), the state’s chief cannabis regulator.
The state has 26 cultivators in the process of establishing operations as well as a handful of micro-cultivators, she added.
“I don’t think we have a concern about the supply,” Krasselt noted.
Preserving the medical market
Meanwhile, Still River Wellness is doubling its retail space to about 2,500 square feet in anticipation of attracting a much larger customer base.
The company serves about 2,000 medical patients at its Torrington dispensary in northwest Connecticut.
Though Still River Wellness was approved a few weeks ago to sell recreational marijuana, ongoing construction to build and parse out that operation from its medical marijuana store will likely push its first adult-use sale to early February.
“Basically, two centers all in one,” Still River Managing Partner Thomas Macre said.
As part of Still River’s MMJ preservation plan – a state requirement aimed to maintain product supply and seamless transactions for medical patients – the property will feature separate parking lots, entrances, reception areas and points-of-sale.
Macre doesn’t expect many of his 300 or so daily medical patients to switch to recreational consumers, a common development in other markets.
“I don’t think that’s going to decline very much because of the product availability, the allotments and taxes,” he said.
“Most of these medical patients are here daily. I don’t see them transferring over to the adult side.”
Under Connecticut’s adult-use program, THC is capped at 30% for flower and 60% for all other cannabis products – restrictions excluded from the medical market.
Other marketplace distinctions include:
- Products administered like medicine, including capsules, pills, suppositories and under-the-tongue sublinguals, are prohibited for recreational consumers.
- Medical marijuana products are tax-free, and the state plans to eliminate the $100 fee for MMJ patient cards, regulators told MJBizDaily.
- Recreational marijuana consumers can possess up to 1.5 ounces of cannabis product; medical patients can possess up to 5 ounces.
“Preserving the medical market was definitely top of mind for DCP as well as the lawmakers in Connecticut when they were crafting legislation,” Krasselt said.
“Our medical market has been in existence for a little over 10 years, and we have a little more than 50,000 patients who come to rely on that medicine.”
Sales in Connecticut’s MMJ market this year are expected to hit $175 million to $215 million, according to MJBizDaily projections.
Supply and demand
By law, Connecticut couldn’t open its adult-use market until regulators approved at least 250,000 square feet of growing and manufacturing space held by its four existing medical marijuana producers, an affirmation that came only a month ago.
That mandate, like the transaction limit, was implemented to ensure product availability in both the medical and recreational markets.
In preparation for the Jan. 10 launch, CT Pharma increased its SKUs (stock-keeping units) and production capacity for flower, pre-rolls, vapes, concentrates and edibles, according to Rino Ferrarese, executive vice president for Verano’s Northern Region. Verano also operates two Zen Leaf dispensaries in the state.
“We have expanded our cultivation areas, invested in additional automation, redesigned product packaging and labels to meet the new adult-use regulations, and implemented Connecticut’s new seed-to-sale tracking system,” he said.
Curaleaf expanded its edibles production capacity and stockpiled inventory to ensure ample supplies for existing medical patients and new adult-use consumers.
“We are also in the process of expanding our processing and production facility, which is scheduled for completion by the end of Q1,” Darin said.
Fine Fettle is tripling the amount of inventory at its recreational stores in Newington, Willimantic and Stamford, which is located near the New York state line.
“We expect it to be busy, so we’re stacking up on a ton of inventory from the producers and getting ready for what we expect to be pretty good demand,” Zachs said.
Business
Alleged Crores Pharma Scam Mastermind Arrested from Surat
After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.
Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.
Fake Business Deals and Dishonoured Cheques Used in Fraud
Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.
In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”
Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.
Multiple Identities and Repeated Fraud Pattern
Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.
Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.
Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.
Multi-State Surveillance Leads to Arrest in Surat
A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.
Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.
Growing Threat of Corporate Identity Fraud
The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.
Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.
Experts Urge Stronger Due Diligence in High-Value Transactions
Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.
Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.
Business
EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices
A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.
Investigation Under Digital Markets Act Gains Momentum
The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.
Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.
Industry Groups Demand Swift Action
Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.
Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.
In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.
Google Denies Allegations
Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.
However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.
Potential Billion-Euro Penalties
If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.
Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.
Wider Implications for Big Tech
The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.
A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.
As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.
AI & Technology
Amazon Faces Potential Criminal Trial in Italy Over €1.2 Billion Tax Evasion Allegations
Milan: U.S. tech giant Amazon is facing the prospect of a major legal showdown in Italy, after prosecutors in Milan formally requested a court to move forward with criminal proceedings over alleged tax evasion totaling approximately ₹12,500 crore (€1.2 billion).
The case targets Amazon’s European division along with four senior executives, marking one of the most significant tax-related investigations involving a global e-commerce platform in Europe.
Trial Push Despite Multi-Million Euro Settlement
The move comes even after Amazon reached a financial settlement with Italian tax authorities in December, agreeing to pay around ₹5,500 crore (€527 million), including interest, to resolve part of the dispute.
Typically, such settlements lead to the closure of criminal investigations. However, Milan prosecutors have opted to proceed, signaling a tougher stance on alleged corporate tax violations.
A preliminary hearing is expected in the coming months, where a judge will decide whether to formally indict the company and its executives or dismiss the case.
Allegations of VAT Evasion Through Marketplace Sellers
At the center of the investigation are claims that Amazon’s platform enabled non-European Union sellers to avoid paying value-added tax (VAT) on goods sold to Italian consumers between 2019 and 2021.
Prosecutors allege that the company’s marketplace structure allowed thousands of foreign vendors—many reportedly based in China—to operate without fully disclosing their identities or tax obligations. This, authorities argue, led to substantial VAT losses for the Italian government.
Under Italian law, online platforms facilitating sales can be held partially liable if third-party sellers fail to comply with tax requirements, a key point in the prosecution’s case.
Italian Government Named as Affected Party
In their filing, prosecutors identified Italy’s Economy Ministry as the injured party, citing significant financial damage resulting from the alleged tax evasion.
Legal experts say the outcome of the case could have wide-ranging implications across the European Union, where VAT systems are harmonized and similar compliance rules apply to digital marketplaces.
Multiple Investigations Add to Pressure
The VAT probe is just one of several legal challenges facing Amazon in Italy. The European Public Prosecutor’s Office is reportedly examining additional tax-related issues covering more recent years.
Meanwhile, Milan authorities are pursuing separate investigations into alleged customs fraud linked to imports from China and whether Amazon maintained an undeclared “permanent establishment” in Italy—potentially exposing it to higher tax liabilities.
In a separate regulatory action, Italy’s data protection authority recently ordered an Amazon unit to stop using personal data from over 1,800 employees at a warehouse near Rome.
Amazon Denies Allegations
Amazon has consistently denied wrongdoing and indicated it will strongly contest the allegations in court if the case proceeds. The company has also warned that prolonged legal uncertainty could impact investor confidence and Italy’s appeal as a destination for international business.
Broader Impact on Europe’s Digital Economy
If the case moves to trial, it could become a landmark moment for the regulation of global e-commerce platforms in Europe. Governments across the region are increasingly scrutinizing how digital marketplaces handle tax compliance, especially in cross-border transactions.
With online retail continuing to expand, regulators are under mounting pressure to ensure that multinational platforms and third-party sellers adhere to the same tax rules as traditional businesses.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
